Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CDP Equity is an Italian state-owned holding and investment company wholly owned by the CDP Group (Cassa Depositi e Prestiti). It acts as a long-term strategic investor in companies of national interest and, through asset-management subsidiaries and fund structures, is active in venture capital, private equity, and private debt. The company is not itself a biotech, pharma, or healthcare operating company, although it has participated in selected health-related investments such as digital health and biotech-focused funding initiatives. Its business centers on capital allocation, portfolio management, and support for innovation, industrial development, and internationalization of Italian enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDP Equity.